Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase II Trial in Patients with Thyroid Eye Disease 2021-10-19 17:52
FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick 2021-10-19 15:01
CARB-X Funds the 3rd Round of Debiopharm's Targeted Antibiotic Program to Combat Resistant N. gonorrhoeae Infections 2021-10-19 09:00
Australian businesses invited to advance the future of healthcare technologies in the Medtronic APAC Innovation Challenge 2021-10-19 06:51
Farmmi Healthcare Subsidiary Receives BRC and HACCP Certifications 2021-10-18 20:00
I-Mab Announces IND Approval for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China 2021-10-18 20:00
WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers 2021-10-18 11:05
Alphamab Oncology Completed Enrollment in the First Pivotal Phase III Clinical Study of the Bispecific Antibody KN046 2021-10-18 10:19
Dole Sunshine Company Partners With EDB New Ventures To Create A New Business In Specialty Ingredients Developed From Fruit Side-streams 2021-10-18 09:00
UPL Announces Long-term Collaboration With Chr. Hansen To Develop And Commercialize Microbial Solutions For Sustainable Agriculture 2021-10-16 05:04
Novavax to Participate in World Vaccine Congress Europe 2021-10-16 04:39
CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform 2021-10-15 20:50
Antengene to Present Data of Its PD-L1/4-1BB Bispecific Antibody ATG-101 and ERK1/2 Inhibitor ATG-017 at SITC 2021 2021-10-15 13:33
International Biopharma Industry Week Shanghai 2021 Opens 2021-10-15 12:22
Qiming's Portfolio Company Abbisko Lists on Main Board of HKEx 2021-10-15 12:00
GV20 Oncotherapy Completes Series B Financing to Advance Pipeline into the Clinic and Expand Immuno-Oncology Drug Discovery Platform 2021-10-14 23:55
Gan & Lee Pharmaceuticals Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA) 2021-10-14 20:46
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with Its AI Immunology Platforms 2021-10-14 19:30
BioAgilytix Closes Acquisition of Australia-based 360biolabs® 2021-10-14 19:00
BioAgilytix Closes Acquisition of Australia-based 360biolabs® 2021-10-14 19:00
1 204 205 206 207 208 440